发明名称 |
MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE |
摘要 |
<p num="1"><br/><br/><br/>The present invention provides double-stranded RNA molecules that mediate RNA <br/>interference in target cells, preferably hepatic cells. The invention also <br/>provides double-stranded RNA (dsRNA) molecules that are modified to be <br/>resistant to nuclease degradation, which inactivates a virus, and more <br/>specifically, hepatitis C virus (HCV). The invention also provides a method of <br/>using these modified RNA molecules to inactivate virus in mammalian cells and <br/>a method of making modified small interfering RNAs (siRNAs) using human Dicer. <br/>The invention provides modified RNA molecules that are modified to include a <br/>dsRNA or siRNA wherein one or more of the pyrimidines in the RNA molecule are <br/>modified to include 2''-Fluorine. The invention also provides dsRNA or siRNA in <br/>which all pyrimidines are modified to include a 2''-Fluorine. The invention <br/>provides that the 2''-Fluorine dsRNA or siRNA molecule is further modified to <br/>include a two base deoxynucleotide "TT" sequence at the 3'' end of the molecule.<br/>
|
申请公布号 |
CA2581651(A1) |
申请公布日期 |
2006.04.13 |
申请号 |
CA20052581651 |
申请日期 |
2005.09.30 |
申请人 |
NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
发明人 |
HOUGHTON, MICHAEL;HAN, JANG |
分类号 |
A61K48/00;A61K31/22;A61K31/7105;C12N15/113;C12Q1/70 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|